Navigation Links
Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
Date:3/14/2012

middleeast.com.

About Omnaris®

Omnaris®(ciclesonide) Nasal Spray is a new intranasal corticosteroid therapy that has been studied extensively in thousands of patients with either seasonal or perennial allergic rhinitis and shown to be effective and well tolerated for both conditions.

Formulated as a pro-drug and in a unique hypotonic formulation, Omnaris® addresses some important improvements on allergic rhinitis treatments such as: drug activation on the target cells, fast onset of action (studies have shown onset of action within 1 to 6 hours), increased absorption of ciclesonide and longer retention in the nasal mucosa compared to isotonic formulations, low systemic availability (1 percent) and low spray volume leading to a safety and tolerability profile compared to placebo, convenience of once daily dosage and efficacy in all main allergic rhinitis symptoms (runny nose, itchy nose, sneezing and nasal congestion).

The UAE is the first country in the Middle East to launch Omnaris® and further launches are expected throughout 2012 and 2013. Omnaris® Nasal Spray is currently approved and launched in the USA, Canada, Argentina, Brazil, Mexico; Hong Kong, Malaysia, South Korea and the Philippines.

About Nycomed, a Takeda Company

Nycomed is a Takeda company since end of September 2011. Takeda is a research-based global company with its main focus on pharmaceuticals. The combined company has an active commercial presence in the therapeutic areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management.

Takeda's traditional strengths in North America, Japan, and the rest of Asia, are now complemented by Nycomed's position in Europe and the high growth emerging markets. The combined company has a presence in more than 70 countries worldwide and ranked 12th by global Rx sales, 14th i
'/>"/>

SOURCE Takeda
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimers Disease Biomarker in Combination with Pioglitazone
2. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
3. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
4. Synthetic Genomics Inc. and Plenus, S.A. de C.V. Form New Sustainable Agriculture Company, Agradis, Inc. to Develop and Commercialize Products Using Genomic Technologies
5. Poplar Healthcare Forms Parent Company, Launches New Web Site
6. CorCell, a Cord Blood America Company, Launches Referral Rewards Program
7. BioCells, Inc., a Cord Blood America Company, to Begin Storing Dental Pulp Stem Cells in Argentina
8. New Oral Biologics Delivery Company, Entrega, Announces Strategic Partnership with Pharma
9. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
10. Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 Swine Flu Virus Outbreak
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Global Stem ... announced plans for the company’s first cellular and regenerative ... by a full day, hands-on stem cell training class ... Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) ... community’s increasing interest in regenerative medicine and recent advances ...
(Date:5/26/2015)... FORT WORTH, Texas , May 26, 2015 /PRNewswire-USNewswire/ ... North Texas Health Science Center to detect early Alzheimer,s ... screen older adults. Detailed standardized guidelines that ... in practice have been published in Alzheimer,s & ... continued efforts of an international working group that includes ...
(Date:5/26/2015)... , 26. mája 2015 ... mene svojej rodiny prezidentom Barackovi Obamovi a Billovi ... súvislosti so stratou Dr. Rongxiang Xu , ... http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu bol pionier, ... a jeho odhodlanie v oblasti vedy a príkladné ...
(Date:5/26/2015)... JERUSALEM , May 26, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has submitted the study protocol for the company,s ... to the U.S. Food and Drug Administration (FDA). The ... Drug (IND) application. The Phase IIb study ...
Breaking Biology Technology:Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... Dec. 21, 2010 Exagen Diagnostics, Inc., a specialty ... today announced that it has been awarded $400,000 in ... program, which was created by Congress as part of ...  Proceeds from the grants will be used to advance ...
... M. Golubieski, president of Foundation Venture Capital Group, LLC, ... Snowdon Inc., a company in which FVCG has invested, ... of Defense (DoD) Program, Transformational Medical Technologies (TMT). ... (DTRA) contract, Snowdon may receive up to $8.2 million ...
... knows how to make an exact cut on a metal rod. ... a carbon nanotube, with a diameter 1/50,000th the thickness of a ... British journal Proceedings of the Royal Society A , researchers ... how single-walled carbon nanotubes are cut, a finding that could lead ...
Cached Biology Technology:Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 3How do you cut a nanotube? Lots of compression 2
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... April 21, 2015 High ... policies are boosting access control systems market in ... to a recently published report by TechSci Research " ... the access control systems market in Saudi ... by 2020.The access control systems market in the Kingdom ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... to remove contaminants from soil, scientists at the ... and their Belgium colleagues at Hasselt University have ... on marginal land. The findings, published in the ... Environmental Microbiology , may help scientists design strategies ...
... the FDA has approved the first human clinical trial ... considerations, but not only, or even primarily, because what ... Although deep-seated disagreements about the ethics of embryo ... to focus as well on this being the first ...
... (ACMG) will hold its 16th Annual Clinical Genetics Meeting ... at the Tampa Convention Center. Clinical and medical ... a dizzying pace and the 2009 ACMG Annual Clinical ... and scientific media to learn firsthand about the latest ...
Cached Biology News:Scientists identify bacteria that increase plant growth 2Scientists identify bacteria that increase plant growth 3Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29 2
...
... This monoclonal antibody recognizes 30% of ... individuals. It does not cross-react ... lacking rheumatoid factor nor with pooled ... used in ELISA to detect rheumatoid ...
...
Human VEGF R2 (KDR) MAb (Clone 89106)...
Biology Products: